Stockscreener 앱 받기
76.22
0.29%
0.22
시간 외 거래:
75.97
-0.25
-0.33%
전일 마감가:
$76.00
열려 있는:
$75.77
하루 거래량:
3.05M
Relative Volume:
0.80
시가총액:
$29.89B
수익:
$4.30B
순이익/손실:
$571.50M
주가수익비율:
52.93
EPS:
1.44
순현금흐름:
$570.80M
1주 성능:
-5.33%
1개월 성능:
-4.93%
6개월 성능:
+7.72%
1년 성능:
+10.75%
1일 변동 폭
$75.39
$76.69
1주일 범위
$75.39
$79.65
52주 변동 폭
$57.52
$93.25
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
DXCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
76.22 | 29.80B | 4.30B | 571.50M | 570.80M | 1.44 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside - inkl
Acadian Asset Management LLC Has $12.87 Million Stake in DexCom, Inc. $DXCM - MarketBeat
30,516 Shares in DexCom, Inc. $DXCM Bought by Fred Alger Management LLC - MarketBeat
MBB Public Markets I LLC Takes Position in DexCom, Inc. $DXCM - MarketBeat
Insider Selling: DexCom (NASDAQ:DXCM) Director Sells 667 Shares of Stock - MarketBeat
Voleon Capital Management LP Buys 19,188 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom (NASDAQ:DXCM) Stock Rating Lowered by Oppenheimer - MarketBeat
Adage Capital Partners GP L.L.C. Sells 540,000 Shares of DexCom, Inc. $DXCM - MarketBeat
Alliancebernstein L.P. Decreases Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom (NASDAQ:DXCM) EVP Sadie Stern Sells 1,466 Shares - MarketBeat
Continuous Glucose Monitor Apps Correction: Dexcom, Inc. Issues Correction for G7 Apps and ONE+ Apps due to a Software Design Error That Does Not Alert Users of Unexpected Sensor Failure - TAPinto
Federation des caisses Desjardins du Quebec Decreases Stock Position in DexCom, Inc. $DXCM - MarketBeat
Nissay Asset Management Corp Japan ADV Has $6.56 Million Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Acquired by Teza Capital Management LLC - MarketBeat
AQR Capital Management LLC Purchases 100,824 Shares of DexCom, Inc. $DXCM - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Mattson Financial Services LLC Purchases 7,257 Shares of DexCom, Inc. $DXCM - MarketBeat
Jacobs Levy Equity Management Inc. Has $23.35 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
Scientech Research LLC Boosts Position in DexCom, Inc. $DXCM - MarketBeat
Dexcom Issues Recall for G7, ONE+ Apps for Software Issues - Medscape
DexCom stock rating reiterated at Overweight by Piper Sandler - Investing.com
Intech Investment Management LLC Trims Stake in DexCom, Inc. $DXCM - MarketBeat
Woodline Partners LP Decreases Holdings in DexCom, Inc. $DXCM - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Buys 1,868,241 Shares of DexCom, Inc. $DXCM - MarketBeat
Great Lakes Advisors LLC Purchases 13,664 Shares of DexCom, Inc. $DXCM - MarketBeat
Kuehn Law Encourages Investors of DexCom, Inc. to Contact Law Firm - Eastern Progress
Parkman Healthcare Partners LLC Increases Stock Position in DexCom, Inc. $DXCM - MarketBeat
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.47%
1.14%
자본화:
|
볼륨(24시간):